Home / TechnologyTechnologyThe New York TimesTechnologyThe New York Times·Sep 7, 2026·1 min readEarly Data Indicates an A.I.-Generated Drug Could Slow AgingArtificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.View original source — The New York Times ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessSep 7, 2026 · 1 minAI-Discovered Drug Reverses Aging Markers in Study, Biotech SaysBloombergTechnologyNatureTechnologySep 2, 2026 · 1 minCan GLP-1 drugs slow ageing? Mouse study shows promiseNatureTechnologyNatureTechnologySep 2, 2026 · 1 minLate-life semaglutide treatment slows ageing and extends lifespan in female miceNatureTechnologySouth China Morning PostTechnologyJun 6, 2026 · 1 minTargeting US$610 billion longevity market, biotech firms race to reverse ageingSouth China Morning Post
BusinessBloombergBusinessSep 7, 2026 · 1 minAI-Discovered Drug Reverses Aging Markers in Study, Biotech SaysBloomberg
TechnologyNatureTechnologySep 2, 2026 · 1 minCan GLP-1 drugs slow ageing? Mouse study shows promiseNature
TechnologyNatureTechnologySep 2, 2026 · 1 minLate-life semaglutide treatment slows ageing and extends lifespan in female miceNature
TechnologySouth China Morning PostTechnologyJun 6, 2026 · 1 minTargeting US$610 billion longevity market, biotech firms race to reverse ageingSouth China Morning Post